Cargando…

Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies

Detalles Bibliográficos
Autores principales: Adelman, Daphne T., Van Genechten, Dirk, Megret, Clémentine M., Truong Thanh, Xuan-Mai T., Hand, Philippa, Martin, Wendy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999158/
https://www.ncbi.nlm.nih.gov/pubmed/31953807
http://dx.doi.org/10.1007/s12325-020-01226-z
_version_ 1783493932813910016
author Adelman, Daphne T.
Van Genechten, Dirk
Megret, Clémentine M.
Truong Thanh, Xuan-Mai T.
Hand, Philippa
Martin, Wendy A.
author_facet Adelman, Daphne T.
Van Genechten, Dirk
Megret, Clémentine M.
Truong Thanh, Xuan-Mai T.
Hand, Philippa
Martin, Wendy A.
author_sort Adelman, Daphne T.
collection PubMed
description
format Online
Article
Text
id pubmed-6999158
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-69991582020-02-19 Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies Adelman, Daphne T. Van Genechten, Dirk Megret, Clémentine M. Truong Thanh, Xuan-Mai T. Hand, Philippa Martin, Wendy A. Adv Ther Correction Springer Healthcare 2020-01-18 2020 /pmc/articles/PMC6999158/ /pubmed/31953807 http://dx.doi.org/10.1007/s12325-020-01226-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Correction
Adelman, Daphne T.
Van Genechten, Dirk
Megret, Clémentine M.
Truong Thanh, Xuan-Mai T.
Hand, Philippa
Martin, Wendy A.
Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title_full Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title_fullStr Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title_full_unstemmed Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title_short Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
title_sort correction to: co-creation of a lanreotide autogel/depot syringe for the treatment of acromegaly and neuroendocrine tumours through collaborative human factor studies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999158/
https://www.ncbi.nlm.nih.gov/pubmed/31953807
http://dx.doi.org/10.1007/s12325-020-01226-z
work_keys_str_mv AT adelmandaphnet correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies
AT vangenechtendirk correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies
AT megretclementinem correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies
AT truongthanhxuanmait correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies
AT handphilippa correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies
AT martinwendya correctiontococreationofalanreotideautogeldepotsyringeforthetreatmentofacromegalyandneuroendocrinetumoursthroughcollaborativehumanfactorstudies